Anaphylaxis at the Saturday Health Fair

This is anaphylaxis: hypotension plus airway symptoms plus skin findings after an exposure. The order matters.

1. Call 911 immediately and say the word "anaphylaxis." Do not wait to see whether it resolves, and do not send him home.
2. Give epinephrine now - 0.3 mg intramuscularly (0.3 mL of the 1 mg/mL solution) into the anterolateral thigh. This is first-line therapy. Diphenhydramine is an adjunct only, does nothing for airway edema or shock, and must not delay epinephrine.
3. Use the expired ampules. Expired epinephrine is degraded but not dangerous, and in an otherwise epinephrine-less pharmacy it is far better than nothing. Note the expiration and the use in the record, and restock the kit the same day. Using expired epinephrine is a documentation and system failure; withholding epinephrine because it is expired is a patient-safety catastrophe.
4. Position him supine with legs elevated (sitting up if he is struggling to breathe), monitor pulse and respirations, and be ready to repeat epinephrine every 5 to 15 minutes if symptoms persist.
5. Stay with him until EMS arrives and hand off the drug names, lot numbers, times, and doses given.

Legally, the pharmacist is acting within the immunization authority that permitted the administration and within the emergency response the protocol requires. The screening failure is a separate problem to be examined after the patient is safe - but nothing about it changes what happens in the next ninety seconds.

Documentation (same day):

• Time of vaccination, time of symptom onset, vital signs, and the full sequence of interventions with times and doses.
• The epinephrine expiration and the fact that expired product was used, with the reason - a contemporaneous note is credible; a reconstructed one is not.
• That 911 was called and when EMS arrived.
• The patient's disclosure of a prior "bad reaction," and the fact that the screening process did not capture it.

Reporting:

• VAERS. Anaphylaxis is a reportable event; file the report and give the patient the VAERS information. File it even though the patient's reaction may relate to a component rather than the vaccine itself - that is the kind of signal VAERS exists to detect.
• The patient's primary care provider, so the event and the need for a permanent allergy flag follow him. Advise him to tell every future vaccinator, and document that advice.
• The state immunization registry, recording the doses administered and the adverse event, so the next clinician sees it.
• Internal incident review, and notification of the supervising prescriber under the protocol.
• Board of Pharmacy notification if the event reveals a protocol violation the pharmacy cannot correct on its own - an out-of-date emergency kit in a clinic the pharmacy is running is exactly that kind of finding. The pharmacy should also self-audit every kit in every location before the next clinic.

Authority. The pharmacist's legal ability to vaccinate does not come from the fact that vaccines are safe or that the pharmacy advertises a clinic. It depends on the Kentucky statutes and Board regulations that define immunization authority, and on the protocol or prescriber agreement that specifies which vaccines may be given, to which age groups and patient populations, and under what conditions. Three practical consequences:

• If the protocol requires an epinephrine kit with unexpired product and CPR-trained staff, then this clinic was operating outside its own authority before the patient ever sat down.
• Screening is part of the protocol, not a formality. A patient with a prior severe reaction should have been identified and, at minimum, referred rather than vaccinated on the spot.
• The federal emergency authorities that expanded pharmacist vaccinating during the public health emergency are not a general grant of authority and should never be the sole basis for practice.

Program corrections:

• Expiration-date log for every kit, checked monthly and documented with initials; replace the expired ampules immediately.
• Require a documented observation period after vaccination, longer for patients with any prior reaction history.
• Redesign the screening questionnaire so that a prior reaction cannot be answered "no" by omission - ask specifically about prior vaccine reactions, allergies to components, and history of anaphylaxis.
• Train all staff on the anaphylaxis protocol and run a drill.

The legal lesson is that the emergency response is the easy part to get right in hindsight; the violation is the kit that was allowed to expire and the screening that did not ask the question.